Yan Zhao Yating Deng Yi Jiang Wenli Zheng Yanlin Tan Zhiwu Yang Zhihua Wang Feng Xu Zhao Cheng Lingli Yuan Hongling Peng
10.3389/fimmu.2023.1127599
Front Immunol
2023 Mar 8;14:1127599.
hemophagocytic lymphohistiocytosis histiocytic sarcoma programmed death-ligand 1 (pd-l1) sequencing targeted therapy
CC BY
https://pubmed.ncbi.nlm.nih.gov/36969238/
Histiocytic Sarcoma / diagnosis Histiocytic Sarcoma / drug therapy Histiocytic Sarcoma / genetics Lymphohistiocytosis, Hemophagocytic / diagnosis Lymphohistiocytosis, Hemophagocytic / drug therapy Lymphohistiocytosis, Hemophagocytic / genetics
Histiocytic Sarcoma / diagnosis Histiocytic Sarcoma / drug therapy Histiocytic Sarcoma / genetics Lymphohistiocytosis, Hemophagocytic / diagnosis Lymphohistiocytosis, Hemophagocytic / drug therapy Lymphohistiocytosis, Hemophagocytic / genetics Case Reports Research Support, Non-U.S. Gov't Humans Male Middle Aged Mutation Programmed Cell Death 1 Receptor N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide Programmed Cell Death 1 Receptor
PMC10030599
36969238
Case report: Targeting the PD-1 receptor and genetic mutations validated in primary histiocytic sarcoma with hemophagocytic lymphohistiocytosis
2023